Therapeutic Activity of a New Targeted Theranostic Agent for the Peri-Infarct Region in Stroke

Keywords

abstract acknowledge activity administered administration affected agent agents among animal animals antibodies assess best brain capacity cells cholesterol clinical conducted constructed contrary control core coupled damage days designed determined determining develop developed doped drug earlier edema effectiveness encapsulated entities every evolution experienced expressed expression extrusion family film financial formation fraction framework free front health healthy histological hospital hours hydration immune important improving in vivo increment induction infarct initial injections innovation interacts known laboratory land lesion lipid male material maximal mediators ministry minor models molecular molecules neurology permanent previously probes processed program protein proved rats recovery reductions remodeling repetitive report route saline science severely significantly specifically spreading stages stroke studied studies support suture system target targeted targeting targets temporal therapeutic timing tissue tissues treated treatment unaffected unique volume volumes